Article

Funk D, Marinelli PW, Le AD. Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. Alcohol Res Health 29: 186-192

Centre for Addiction and Mental Health, Toronto, Canada.
Alcohol research & health: the journal of the National Institute on Alcohol Abuse and Alcoholism (Impact Factor: 0.58). 02/2006; 29(3):186-92.
Source: PubMed

ABSTRACT

Alcohol and nicotine are two of the oldest and most commonly used recreational drugs, and many people use both of them together. Although their ready availability likely contributes to the strong correlation between alcohol and nicotine use, several lines of evidence suggest that biological factors play a role as well. For example, both alcohol and nicotine act on a brain system called the mesolimbic dopamine system, which mediates the rewarding and reinforcing properties of both drugs. Modification of the activities of the mesolimbic dopamine system can interfere with the effects of both alcohol and nicotine. Another mechanism that may contribute to alcohol-nicotine interactions is cross-tolerance to the effects of both drugs. Finally, genetic studies in humans and of selectively bred mouse and rat strains suggest that shared genetic factors help determine a person's liability to use or abuse both alcohol and nicotine.

Download full-text

Full-text

Available from: Anh D Lê
  • Source
    • "Furthermore, emerging evidence suggests that the exposure of the developing brain to nicotine may potentially lead to long-term adverse consequences for brain function and cognition (Naude et al., 2014; van Ewijk et al., 2014). Finally, some evidence suggests that nicotine can facilitate heavier alcohol use due to its ability to counter alcohol's sedative effects when the substances are used together (Funk et al., 2006) and can serve as a " gateway " drug by paving the way to the use of harder drugs (Kandel and Kandel, 2015). A better knowledge of factors increasing risk for tobacco use is essential for the development of more efficient prevention and intervention methods. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Deficits in self-regulation of behavior can play an important role in the initiation of substance use and progression to regular use and dependence. One of the distinct component processes of self-regulation is error monitoring, i.e. detection of a conflict between the intended and actually executed action. Here we examined whether a neural marker of error monitoring, Error-Related Negativity (ERN), predicts future initiation of tobacco use. ERN was assessed in a prospective longitudinal sample at ages 12, 14, and 16 using a flanker task. ERN amplitude showed a significant increase with age during adolescence. Reduced ERN amplitude at ages 14 and 16, as well as slower rate of its developmental changes significantly predicted initiation of tobacco use by age 18 but not transition to regular tobacco use or initiation of marijuana and alcohol use. The present results suggest that attenuated development of the neural mechanisms of error monitoring during adolescence can increase the risk for initiation of tobacco use. The present results also suggest that the role of distinct neurocognitive component processes involved in behavioral regulation may be limited to specific stages of addiction. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
    Full-text · Article · Aug 2015
  • Source
    • "It is thus possible that the minor allele of the rs2948694 alters the sensitivity of the cholinergic-dopaminergic reward link, which in turn may lead to a predisposition to smoking and increased alcohol consumption, reflected by the higher AUDIT scores in the present study. Previous studies show that alcohol and nicotine dependence share a genetic background (True et al. 1999; Funk, Marinelli & Le 2006; von der Pahlen et al. 2008). This is further supported by the welldocumented co-use of alcohol and nicotine—also observed in the present study—and the neurobiological interaction between alcohol and nicotine within the mesolimbic dopamine system (for review, see Larsson & Engel 2004; Soderpalm, Lof & Ericson 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The multifaceted gut-brain peptide ghrelin and its receptor (GHSR-1a) are implicated in mechanisms regulating not only the energy balance but also the reward circuitry. In our pre-clinical models, we have shown that ghrelin increases whereas GHSR-1a antagonists decrease alcohol consumption and the motivation to consume alcohol in rodents. Moreover, ghrelin signaling is required for the rewarding properties of addictive drugs including alcohol and nicotine in rodents. Given the hereditary component underlying addictive behaviors and disorders, we sought to investigate whether single nucleotide polymorphisms (SNPs) located in the pre-proghrelin gene (GHRL) and GHSR-1a gene (GHSR) are associated with alcohol use, measured by the alcohol use disorders identification test (AUDIT) and smoking. Two SNPs located in GHRL, rs4684677 (Gln90Leu) and rs696217 (Leu72Met), and one in GHSR, rs2948694, were genotyped in a subset (n = 4161) of a Finnish population-based cohort, the Genetics of Sexuality and Aggression project. The effect of these SNPs on AUDIT scores and smoking was investigated using linear and logistic regressions, respectively. We found that the minor allele of the rs2948694 SNP was nominally associated with higher AUDIT scores (P = 0.0204, recessive model) and smoking (P = 0.0002, dominant model). Furthermore, post hoc analyses showed that this risk allele was also associated with increased likelihood of having high level of alcohol problems as determined by AUDIT scores ≥ 16 (P = 0.0043, recessive model). These convergent findings lend further support for the hypothesized involvement of ghrelin signaling in addictive disorders. © 2015 Society for the Study of Addiction.
    Full-text · Article · Jul 2015 · Addiction Biology
  • Source
    • "For example, pharmacological and/or genetic manipulation of various nAChRs such as α4β2*, α3β4*, and α3/α6β2* subtypes (* indicates the possible inclusion of other subunits) were shown to modulate ethanol selfadministration and ethanol-induced elevation of accumbal dopamine levels in rodents (Chatterjee et al., 2011; Hendrickson et al., 2010; Jerlhag et al., 2006; Kamens et al., 2010). Moreover, given the strong correlation between nicotine and ethanol abuse (DiFranza and Guerrera, 1990; Funk et al., 2006), it was further demonstrated that nicotine treatment re-instates ethanol seeking behaviors in rats following extinction of ethanol reinforcement (Lê et al., 2003; Hauser et al., 2012). In addition, nAChRs are previously shown to regulate deprivation-induced re-exposure of ethanol seeking in long-term ethanol experienced rats (Kuzmin et al., 2009; Rezvani et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Relapse is a core feature of alcohol addiction and hinders the pharmacotherapy of alcohol use disorders. Pre-clinical and clinical studies have shown that neuronal nicotinic acetylcholine receptor (nAChR) partial agonists such as cytisine and its derivative, varenicline, reduce alcohol (ethanol) consumption and seeking behavior. However, the effects of these ligands on ethanol relapse are little understood. In the present study, we examined the effects of varenicline and cytisine on alcohol deprivation effect (ADE) - a validated model for relapse-like ethanol drinking in C57BL/6J mice. After habituation to 15% (v/v) ethanol intake using a continuous free-choice procedure, mice were exposed to alternating cycles of ethanol deprivation (5 days) and re-exposure (2 days). At the end of third deprivation cycle, animals received repeated intraperitoneal injections of saline, varenicline (0.5 or 3.0 mg/kg) or cytisine (0.5 or 3.0 mg/kg) and fluid intake was measured post 4 h and 24 h ethanol re-exposure. Repeated ethanol deprivation and re-exposure cycles significantly produced a robust and transient increase in ethanol (ADE). Pretreatment with varenicline (0.5 or 3.0 mg/kg) or cytisine (0.5 or 3.0 mg/kg) significantly reduced the expression of ADE at 4 h and 24 h after ethanol re-exposure. The results from this study indicate that nAChR partial agonists reduce the expression of ADE in mice and further suggest the involvement of nAChR mechanisms in ADE, a relapse-like ethanol drinking behavior.
    Full-text · Article · Jul 2013 · Pharmacology Biochemistry and Behavior
Show more